Speaker illustration

Professor Ajay Kakkar

Thrombosis Research Institute, London (United Kingdom of Great Britain & Northern Ireland)

What is the long term impact of atrial fibrillation? Insights from GARFIELD-AF

Event: ESC CONGRESS 2019

Topic: Stroke Prevention

Session type: Satellite Symposium

Thumbnail

Rivaroxaban in cardiovascular protection - Getting to the heart of the matter

Event: ESC Congress 2018

Topic: Cardiovascular Disease in Special Populations

Session type: Satellite Symposium

Thumbnail

GARFIELD-AF: new light shed on atrial fibrillation and its management

Event: ESC Congress 2018

Topic: Atrial Fibrillation (AF)

Session type: Satellite Symposium

Thumbnail

Atrial fibrillation – A bystander or cause of morbidity and mortality: insights from the GARFIELD-AF registry

Event: ESC CONGRESS 2017

Topic: Atrial fibrillation (AF)

Session type: Satellite Symposium

Thumbnail

Risk profiles for patients with atrial fibrillation and the quality of stroke prevention: results from the GARFIELD-AF registry

Event: ESC CONGRESS 2016

Topic: Atrial fibrillation (AF)

Session type: Satellite Symposium

Thumbnail

Anticoagulation and Atrial Fibrillation (AF): real life data from the GARFIELD-AF Registry

Event: ESC CONGRESS 2015

Topic: Atrial fibrillation (AF)

Session type: Satellite Symposium

Thumbnail

From acute PE to CTEPH: related diseases, different solutions

Event: ESC CONGRESS 2014

Topic: Chronic pulmonary hypertension

Session type: Satellite Symposium

Thumbnail

Anticoagulation and atrial fibrillation: emerging insights

Event: ESC CONGRESS 2014

Topic: Atrial fibrillation (AF)

Session type: Satellite Symposium

Thumbnail

Stroke prevention in atrial fibrillation 2013: registry insights and perspectives

Event: ESC Congress 2013

Topic: Atrial fibrillation (AF)

Session type: Satellite Symposium

Thumbnail

This platform is supported by

logo Novo Nordisk